The platform offers AI models and agents that help scientists design, test and iterate experiments to identify and analyze ...
New York, USA, April 13th, 2026, FinanceWireMonce’s next stage of growth depended not just on product capability, ...
AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery.
As enterprises struggle to govern rapidly multiplying AI agents, AWS is offering a centralized registry to bring visibility, ownership, and lifecycle control.
AWS, Microsoft and Google are building agent governance layers from different starting points. The battle over discovery and ...
Amazon Bio Discovery uses a library of biological foundational models to design and run antibody research experiments.
The box on the doorstep, particularly during the pandemic, has come to symbolize Amazon and society's dependance on it.
Ataccama, the data trust company, today announced that its Ataccama ONE data trust platform will provide capabilities that empower financial institutions to meet the requirements of the EU AI Act.
Anthropic is reshaping enterprise AI as Claude Code boosts productivity and adoption. Click for this look at ANTHRO, its ...
The experiments involved asking about 2,000 eBook readers to browse a catalog of titles available on the Kindle eReader, and ...
Amazon Web Services (AWS) has launched the AWS Agent Registry, a single, central library for all your company’s AI agents, ...
Health and Me on MSN
Amazon's new AI tool to accelerate early-stage drug discovery
Amazon Bio Discovery also enables scientists to securely feed prior experimental data from their organization's lab results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results